Transfusion Diagnostics: Strategic Assessments of Current and Emerging Competitors
This new report from VPGMarketResearch.com provides extensive analyses of major current and emerging suppliers of transfusion diagnostic instruments and reagents. The assessments include: Sales Product portfolios Marketing tactics Technological know-how New products in R&D Collaborative arrangements Business strategies.
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
OrthoClinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/GenProbe
Immucor
OrthoClinical Diagnostic
Proteome Sciences
Quest
Quidel
Roche
Siemens
Tecan
Thermo Fisher/Life Technologies
More Publications
Blood Typing, Grouping and Infectious Disease NAT Screening: Strategic Assessments of Current and Emerging Competitors
US$ 2,800.00
July 2016
225 pages
2015 Transfusion Diagnostics Market: Strategic Assessments of Current and Emerging Competitors
US$ 1,960.00
October 2015
50 pages
2016-2020 Transfusion Diagnostics Market: Strategic Assessments of Current and Emerging Competitors
US$ 1,960.00
March 2016
50 pages
2015 Strategic Assessments of Current and Emerging Transfusion Diagnostics Market Players
US$ 1,960.00
July 2015
50 pages
2015 Cancer Diagnostics Market: Strategic Assessments of Current and Emerging Competitors
US$ 2,000.00
October 2015
80 pages
